| Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma MV Heppt, A Roesch, B Weide, R Gutzmer, F Meier, C Loquai, KC Kähler, ... European Journal of Cancer 81, 36-44, 2017 | 121 | 2017 |
| SF3B1 and BAP1 mutations in blue nevus-like melanoma KG Griewank, H Müller, LA Jackett, M Emberger, I Möller, ... Modern Pathology 30 (7), 928-939, 2017 | 113 | 2017 |
| Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles KG Griewank, T Wiesner, R Murali, C Pischler, H Müller, C Koelsche, ... Modern Pathology 31 (3), 418-428, 2018 | 104 | 2018 |
| NF1 mutations in conjunctival melanoma SL Scholz, I Cosgarea, D Süßkind, R Murali, I Möller, H Reis, ... British Journal of Cancer 118 (9), 1243-1247, 2018 | 96 | 2018 |
| Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations I Cosgarea, S Ugurel, A Sucker, E Livingstone, L Zimmer, M Ziemer, ... Oncotarget 8 (25), 40683, 2017 | 85 | 2017 |
| Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi I Möller, R Murali, H Müller, T Wiesner, LA Jackett, SL Scholz, I Cosgarea, ... Modern Pathology 30 (3), 350-356, 2017 | 72 | 2017 |
| Acral peeling skin syndrome with TGM5 gene mutations may resemble epidermolysis bullosa simplex in young individuals D Kiritsi, I Cosgarea, CW Franzke, H Schumann, V Oji, J Kohlhase, ... Journal of Investigative Dermatology 130 (6), 1741-1746, 2010 | 60 | 2010 |
| GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma E Livingstone, A Zaremba, S Horn, S Ugurel, B Casalini, M Schlaak, ... British Journal of Dermatology 183 (5), 928-939, 2020 | 51 | 2020 |
| Clinical and genetic analysis of melanomas arising in acral sites A Zaremba, R Murali, P Jansen, I Möller, A Sucker, A Paschen, L Zimmer, ... European Journal of Cancer 119, 66-76, 2019 | 46 | 2019 |
| Photoaging mobile apps as a novel opportunity for melanoma prevention: pilot study TJ Brinker, D Schadendorf, J Klode, I Cosgarea, A Rösch, P Jansen, ... JMIR mHealth and uHealth 5 (7), e8231, 2017 | 43 | 2017 |
| Cutaneous manifestations in inflammatory bowel disease L Ungureanu, R Cosgarea, M Alexandru Badea, A Florentina Vasilovici, ... Experimental and Therapeutic Medicine 20 (1), 31-37, 2020 | 38 | 2020 |
| Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom I Cosgarea, C Ritter, JC Becker, D Schadendorf, S Ugurel JDDG: Journal der Deutschen Dermatologischen Gesellschaft 15 (9), 887-894, 2017 | 37 | 2017 |
| Role of dermoscopy in the assessment of basal cell carcinoma L Ungureanu, I Cosgarea, S Şenilǎ, A Vasilovici Frontiers in Medicine 8, 718855, 2021 | 32 | 2021 |
| Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma I Cosgarea, Z Lovric, A Körber, J Dissemond International Wound Journal 13 (5), 1041, 2014 | 32 | 2014 |
| Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration I Cosgarea, AT McConnell, T Ewen, D Tang, DS Hill, M Anagnostou, ... British Journal of Dermatology 186 (4), 694-704, 2022 | 26 | 2022 |
| Deep penetrating nevus and borderline-deep penetrating nevus: a literature review I Cosgarea, KG Griewank, L Ungureanu, A Tamayo, T Siepmann Frontiers in Oncology 10, 837, 2020 | 24 | 2020 |
| A smoking prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised trial BL Faria, CM Brieske, I Cosgarea, AJ Omlor, FN Fries, COM de Faria, ... BMJ open 7 (12), e018589, 2017 | 21 | 2017 |
| Oncogene status as a diagnostic tool in ocular and cutaneous melanoma KG Griewank, B Schilling, SL Scholz, CH Metz, E Livingstone, A Sucker, ... European Journal of Cancer 57, 112-117, 2016 | 19 | 2016 |
| Multiple primary melanomas: Our experience L Ungureanu, I Zboraș, A Vasilovici, Ș Vesa, I Cosgarea, R Cosgarea, ... Experimental and Therapeutic Medicine 21 (1), 88, 2021 | 16 | 2021 |
| PD-1 receptor deficiency enhances CD30+ Treg cell function in melanoma JX Lim, T McTaggart, SK Jung, KJ Smith, G Hulme, S Laba, YQ Ng, ... Nature Immunology, 1-13, 2025 | 11 | 2025 |
